Form 8-K - Current report:
SEC Accession No. 0000950170-22-004583
Filing Date
2022-03-24
Accepted
2022-03-24 17:15:09
Documents
15
Period of Report
2022-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20220318.htm   iXBRL 8-K 54122
2 EX-10.1 acet-ex10_1.htm EX-10.1 107490
3 EX-10.2 acet-ex10_2.htm EX-10.2 110841
4 EX-10.3 acet-ex10_3.htm EX-10.3 129778
  Complete submission text file 0000950170-22-004583.txt   540327

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20220318_lab.xml EX-101.LAB 13996
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20220318.xsd EX-101.SCH 2498
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20220318_pre.xml EX-101.PRE 10332
9 EXTRACTED XBRL INSTANCE DOCUMENT acet-20220318_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 22767483
SIC: 2834 Pharmaceutical Preparations